Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
-
J Coll Physicians Surg Pak · Jan 2023
Case ReportsBombay Blood Group: An Incidental Discovery in a Family.
Bombay phenotype is an uncommon blood type. It is found in approximately 1 in 10,000 people in the Indian subcontinent and approximately 1 in 1,000,000 in Europe. ⋯ Herein, we report an incidental discovery of a family with three members having Bombay phenotype on routine antenatal examination. Key Words: ABO blood group system, Bombay phenotype, Cross matching.
-
J Coll Physicians Surg Pak · Jan 2023
Barcode Medication Administration Technology to Prevent Medication Errors.
Medication errors cause harm to patients at any point along the medication administration process and can be prevented. Barcoding medication administration (BCMA) is effective as a clinical decision support system (CDSS) to avoid errors. ⋯ The objective of this article is to increase awareness regarding BCMA and how it can decrease patient morbidity and mortality, enhance safety, and lower overall hospital-associated costs by preventing medication errors. Key Words: Bar-code medication administration, Medication errors, Adverse drug events, Patient safety.
-
J Coll Physicians Surg Pak · Jan 2023
Enhancing Empathy in Medical Students by Focused Learner Centered Activities.
To determine the change in empathy levels of medical students during their progress in professional years internship, and to examine change in empathy after targeted empathy enhancing activities during the course of medical school. ⋯ Medical student empathy, Empathy enhancing targeted activities, JSPE.
-
J Coll Physicians Surg Pak · Jan 2023
Observational StudyPredictive Value of HBsAg for Off-treatment Response in HBeAg-negative Chronic Hepatitis B Patients.
To investigate the virological relapse (VR) rate and prognostic value of the HBsAg level at treatment completion for predicting sustained off-treatment response in HBeAg-negative patients after neucleos(t)ide analog (NA) therapy. ⋯ Hepatitis B surface antigen, Nucleos(t)ide analogs, Cessation, Relapse.
-
J Coll Physicians Surg Pak · Jan 2023
Meta AnalysisCombination Treatment with Iodine 125 Seeds Implant and Systemic Therapy vs. Systemic Therapy Alone for Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis.
Combination treatment with iodine 125 seeds implant and systemic therapy in patients with non-small-cell lung cancer (NSCLC) is a promising treatment practice. The present study aimed to assess the relative efficacy and toxicity of combination treatment versus systemic therapy alone in patients with NSCLC. Databases including PubMed, EBSCO, Web of Science, EMBASE, Cochrane Library, CNKI, and WanFang were searched for relevant randomised controlled trials (RCTs). ⋯ In terms of adverse events, the combination therapy significantly increased the incidence of pneumothorax (RR = 4.91, 95% CI: 2.63 - 9.17, p <0.001); however, no significant differences were found in the incidence of myelosuppression and gastrointestinal symptoms. Combination treatment with iodine 125 seeds implant and systemic therapy can significantly improve clinical response and prolong two-year OS in NSCLC patients without increasing the incidence of myelosuppression and gastrointestinal symptoms, except pneumothorax. Key Words: Brachytherapy, Radioactive seeds, NSCLC, Systemic therapy.